Dr. William George Espar Jr., MD

Dr. Espar practices at Franciscan Health Michigan City in Michigan City, Indiana, part of Franciscan Alliance.

Dr. Espar's NPI, 1952396855, was assigned on September 16, 2005. Dr. Espar graduated from American University of the Caribbean School of Medicine in 1988. Dr. Espar's Indiana license number on file is 01041339A.

Dr. Espar's primary practice is Franciscan Health Michigan City, at 3500 Franciscan Way, Michigan City, IN 46360 in La Porte County. The practice phone is (219) 879-8511.

Dr. Espar's primary practice is Franciscan Health Michigan City in Michigan City, Indiana, part of Franciscan Alliance. Dr. Espar is also affiliated with Franciscan Health Crown Point. The medical group on file is Franciscan Physician Network. Dmand AI also links Dr. Espar to 3 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Espar practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Espar's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Espar is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Espar's licenses on file in 3 states: Indiana, Minnesota and Michigan.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, chronic hypertension, coronary artery disease and endocarditis among the conditions Dr. Espar treats.

CMS data shows 3,771 Medicare services from Dr. Espar across 29 procedure codes in 2024, for 1,723 Medicare patients. Medicare paid $119,017 for them.

CMS counts 1,723 Medicare patients who saw Dr. Espar in 2024. The largest group is 65 to 74, with 686 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Espar's median patient age at 73, with 47% women.

In 2024, Dr. Espar wrote 5,430 Medicare Part D claims for 776 patients. 86% of them were for generic drugs. CMS names the drug for 5,137 of them, across 57 drugs with 11 or more claims each, at $758,960 in total drug cost. In 2023, CMS named 5,036 claims across 60 drugs.

Dr. Espar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of coronary angioplasty and stenting by Dr. Espar, more than 42% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 598 general payments to Dr. Espar from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Medtronic, Inc. paid the most, $3,705.

Dmand AI lists 2 awards for Dr. Espar, most recently ACC Fellow in 2012.

Dr. Espar graduated from American University of the Caribbean School of Medicine in 1988.

Dr. Espar is in network with 15 carriers, including Aetna, Cigna and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.